Source: Eur Respir J, 54 (1) 1901213; 10.1183/13993003.01213-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Irena F. Laska, James D. Chalmers. Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?. Eur Respir J, 54 (1) 1901213; 10.1183/13993003.01213-2019

Member's Comments

No comment yet.

Related content which might interest you: Prevention and treatment of exacerbations of non-CF bronchiectasis Source: Eur Respir Monogr 2013; 60: 127-136 Year: 2013 Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021 Year: 2021 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 Antibiotic treatment and prevention of exacerbations of COPD Source: Eur Respir Monogr 2013; 60: 96-106 Year: 2013 Impact of mucolytic treatment on COPD exacerbations Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Antibiotic treatment strategies in adults with bronchiectasis Source: Eur Respir Mon 2011; 52: 211-222 Year: 2011 Prevention of exacerbations of COPD with pharmacotherapy Source: Eur Respir Rev 2009; 19: 119-126 Year: 2010 COPD exacerbations in old age: how to prevent, detect and treat Source: Eur Respir Mon; 2009: 43: 90–110 Year: 2009 COPD: antibiotic strategy in infectious exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 137s Year: 2001 Acute exacerbations of COPD due to pseudomonas aeruginosa: Impact of antimicrobial resistance Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Double edge sword: antibiotics in the prevention and treatment of COPD exacerbation Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session Year: 2012 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Risk of pneumonia and exacerbations of chronic obstructive pulmonary disease(COPD) with inhaled corticosteroid (ICS) use: a Singapore perspective Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 Erdosteine oral treatment of hospitalised COPD exacerbation prolongs time to first re-exacerbation Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014